UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil

Journal of clinical pharmacology, 2013-04, Vol.53 (4), p.393-402

2013

Volltextzugriff (PDF)

OP61 Stem cell allotransplantation for NHL

Leukemia research, 2007, Vol.31, p.S60-S60

Maloney, D.G

2007

Volltextzugriff (PDF)

PCN90 ASSESSMENT OF UTILITIES FOR ADVERSE EVENTS (AES) ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA (LBCL)

Value in health, 2020-05, Vol.23, p.S39-S39

2020

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Bone marrow transplantation (Basingstoke), 2014-11, Vol.49 (11), p.1360-1365

2014

Volltextzugriff (PDF)

An algorithm for suboptimally placed supraglottic airway devices: the choice of videolaryngoscope

British journal of anaesthesia : BJA, 2017-10, Vol.119 (4), p.843-843

2017

Volltextzugriff (PDF)

Chimeric antigen receptor-modified T cells derived from defined [CD8.sup.+] and [CD4.sup.+] subsets confer superior antitumor reactivity in vivo

Leukemia, 2016-02, p.492

2016

Volltextzugriff (PDF)

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma

Annals of oncology, 2015-11, Vol.26 (11), p.2323-2328

2015

Volltextzugriff (PDF)

Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma

Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (S1), p.S35-S36

Maloney, Dg

2008

Volltextzugriff (PDF)

Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.197-203

2015

Volltextzugriff (PDF)

A randomized study of melphalan 200 mg/[m.sup.2] vs 280 mg/[m.sup.2] as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.67

2016

Volltextzugriff (PDF)

A PILOT TRIAL OF ADRIAMYCIN, PEMBROLIZUMAB, VINBLASTINE AND DACARBAZINE (APVD) FOR PATIENTS WITH UNTREATED CLASSICAL HODGKIN LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.572-573

2019

Volltextzugriff (PDF)

CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

Hematological oncology, 2019-06, Vol.37 (S2), p.307-307

2019

Volltextzugriff (PDF)

SAFETY OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN ADULTS AFTER CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR‐MODIFIED T‐CELL (CAR‐T) THERAPY

Hematological oncology, 2019-06, Vol.37 (S2), p.313-314

2019

Volltextzugriff (PDF)

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Annals of oncology, 2010-06, Vol.21 (6), p.1196-1202

2010

Volltextzugriff (PDF)

Durable responses after CD19‐targeted CAR‐T cell immunotherapy with concurrent ibrutinib for CLL after prior ibrutinib failure

Hematological oncology, 2019-06, Vol.37 (S2), p.168-170

2019

Volltextzugriff (PDF)

HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY

Hematological oncology, 2019-06, Vol.37 (S2), p.170-171

2019

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.804-809

2012

Volltextzugriff (PDF)

Immunotherapy With Rituximab (RITUXAN)/Interleukin 2 (IL-2) Following Autologous Peripheral Blood Stem Cell Transplant (ASCT) as Treatment for CD20 Positive Non-Hodgkin's Lymphoma

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.39-39

2009

Volltextzugriff (PDF)

A Randomized Phase III Trial Investigating 2 Gy TBI Vs. Flu/2 Gy TBI Conditioning for HLA-Matched Related Donor Hematopoietic Cell Transplantation (HCT): Tempo of CD3 and NK Cell Engraftment Determines Relapse and Progression Free Survival in Patients with Hematologic

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S214-S214

2012

Volltextzugriff (PDF)

Association Between Calcineurin Inhibitor Blood Concentrations and Outcomes After Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S168-S168

2011

Volltextzugriff (PDF)

Tandem Autologous and Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-matched Related Or Unrelated Donors for Advanced Lymphoma Or Chronic Lymphocytic Leukemia (CLL)

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.66-66

2009

Volltextzugriff (PDF)

275: Impacts of comorbidities on outcomes of patients (pts) younger than 60 years old, diagnosed with indolent malignancies and treated with allogeneic hematopoietic cell transplantation (HCT)

Biology of blood and marrow transplantation, 2007-02, Vol.13 (2), p.100-100

2007

Volltextzugriff (PDF)

Comorbidity, Lactate Dehydrogenase (LDH), and Chemosensitivity Are Independent Predictors of Mortality after Autologous Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Lymphoma

Blood, 2007-11, Vol.110 (11), p.616-616

2007

Volltextzugriff (PDF)

The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma

Bone marrow transplantation (Basingstoke), 2007-12, Vol.40 (11), p.1039-1044

2007

Volltextzugriff (PDF)

170: Long-Term Outcome of Nonmyeloalative Allografting from HLA-Identical Sibling for Multiple Myeloma (MM)

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.63-63

2008

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Humans
(14)
Immunology
(9)
Adult
(8)
Aged
(8)
Biological And Medical Sciences
(8)
Female
(8)
Lymphoma
(8)
Male
(8)
Middle Aged
(8)
Oncology
(8)
Hematology, Oncology And Palliative Medicine
(7)
Medical Sciences
(7)
Hematology
(6)
Hematopoietic Stem Cell Transplantation
(6)
Stem Cell Transplantation
(6)
Transplantation
(6)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(5)
Animals
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil

OP61 Stem cell allotransplantation for NHL

PCN90 ASSESSMENT OF UTILITIES FOR ADVERSE EVENTS (AES) ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA (LBCL)

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

An algorithm for suboptimally placed supraglottic airway devices: the choice of videolaryngoscope

Chimeric antigen receptor-modified T cells derived from defined [CD8.sup.+] and [CD4.sup.+] subsets confer superior antitumor reactivity in vivo

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma

Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma

Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor

A randomized study of melphalan 200 mg/[m.sup.2] vs 280 mg/[m.sup.2] as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

A PILOT TRIAL OF ADRIAMYCIN, PEMBROLIZUMAB, VINBLASTINE AND DACARBAZINE (APVD) FOR PATIENTS WITH UNTREATED CLASSICAL HODGKIN LYMPHOMA

CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

SAFETY OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN ADULTS AFTER CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR‐MODIFIED T‐CELL (CAR‐T) THERAPY

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Durable responses after CD19‐targeted CAR‐T cell immunotherapy with concurrent ibrutinib for CLL after prior ibrutinib failure

HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy

Immunotherapy With Rituximab (RITUXAN)/Interleukin 2 (IL-2) Following Autologous Peripheral Blood Stem Cell Transplant (ASCT) as Treatment for CD20 Positive Non-Hodgkin's Lymphoma

A Randomized Phase III Trial Investigating 2 Gy TBI Vs. Flu/2 Gy TBI Conditioning for HLA-Matched Related Donor Hematopoietic Cell Transplantation (HCT): Tempo of CD3 and NK Cell Engraftment Determines Relapse and Progression Free Survival in Patients with Hematologic

Association Between Calcineurin Inhibitor Blood Concentrations and Outcomes After Allogeneic Hematopoietic Cell Transplantation

Tandem Autologous and Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-matched Related Or Unrelated Donors for Advanced Lymphoma Or Chronic Lymphocytic Leukemia (CLL)

275: Impacts of comorbidities on outcomes of patients (pts) younger than 60 years old, diagnosed with indolent malignancies and treated with allogeneic hematopoietic cell transplantation (HCT)

Comorbidity, Lactate Dehydrogenase (LDH), and Chemosensitivity Are Independent Predictors of Mortality after Autologous Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Lymphoma

The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma

170: Long-Term Outcome of Nonmyeloalative Allografting from HLA-Identical Sibling for Multiple Myeloma (MM)

Suchergebnisse filtern